2-21015541-C-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000384.3(APOB):​c.3337G>C​(p.Asp1113His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00836 in 1,612,412 control chromosomes in the GnomAD database, including 105 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0073 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 96 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

4
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1U:1B:18

Conservation

PhyloP100: 0.911

Publications

23 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0044953525).
BP6
Variant 2-21015541-C-G is Benign according to our data. Variant chr2-21015541-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 218443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 9 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.3337G>Cp.Asp1113His
missense
Exon 22 of 29NP_000375.3P04114

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.3337G>Cp.Asp1113His
missense
Exon 22 of 29ENSP00000233242.1P04114
APOB
ENST00000673739.2
n.*2643G>C
non_coding_transcript_exon
Exon 21 of 25ENSP00000501110.2A0A669KB70
APOB
ENST00000673882.2
n.*2432G>C
non_coding_transcript_exon
Exon 20 of 23ENSP00000501253.2A0A669KB70

Frequencies

GnomAD3 genomes
AF:
0.00732
AC:
1113
AN:
152042
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00160
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00760
Gnomad ASJ
AF:
0.0127
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.00330
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0120
Gnomad OTH
AF:
0.00767
GnomAD2 exomes
AF:
0.00674
AC:
1681
AN:
249556
AF XY:
0.00678
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00451
Gnomad ASJ exome
AF:
0.0104
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00349
Gnomad NFE exome
AF:
0.0103
Gnomad OTH exome
AF:
0.00849
GnomAD4 exome
AF:
0.00847
AC:
12369
AN:
1460252
Hom.:
96
Cov.:
33
AF XY:
0.00827
AC XY:
6011
AN XY:
726436
show subpopulations
African (AFR)
AF:
0.00143
AC:
48
AN:
33480
American (AMR)
AF:
0.00449
AC:
201
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0102
AC:
267
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00363
AC:
313
AN:
86248
European-Finnish (FIN)
AF:
0.00490
AC:
254
AN:
51840
Middle Eastern (MID)
AF:
0.00711
AC:
41
AN:
5768
European-Non Finnish (NFE)
AF:
0.00975
AC:
10837
AN:
1111976
Other (OTH)
AF:
0.00676
AC:
408
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
621
1242
1863
2484
3105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
378
756
1134
1512
1890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00731
AC:
1113
AN:
152160
Hom.:
9
Cov.:
32
AF XY:
0.00702
AC XY:
522
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.00159
AC:
66
AN:
41492
American (AMR)
AF:
0.00759
AC:
116
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0127
AC:
44
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4822
European-Finnish (FIN)
AF:
0.00330
AC:
35
AN:
10602
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0120
AC:
819
AN:
68012
Other (OTH)
AF:
0.00759
AC:
16
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
62
125
187
250
312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0105
Hom.:
9
Bravo
AF:
0.00699
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.0104
AC:
40
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.0117
AC:
101
ExAC
AF:
0.00682
AC:
828
Asia WGS
AF:
0.00173
AC:
7
AN:
3478
EpiCase
AF:
0.0107
EpiControl
AF:
0.00984

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
6
not specified (7)
-
1
4
Hypercholesterolemia, familial, 1 (5)
-
-
4
not provided (4)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Familial hypercholesterolemia (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
21
DANN
Uncertain
0.99
Eigen
Benign
0.054
Eigen_PC
Benign
-0.046
FATHMM_MKL
Benign
0.65
D
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-0.92
T
PhyloP100
0.91
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-3.2
D
REVEL
Benign
0.10
Sift
Uncertain
0.0060
D
Sift4G
Uncertain
0.0080
D
Vest4
0.27
MVP
0.63
MPC
0.29
ClinPred
0.026
T
GERP RS
3.6
gMVP
0.65
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12713844; hg19: chr2-21238413; COSMIC: COSV99028667; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.